Cogstate Limited (COGZF)

0.8500

0.0000

(0.00%)

At close: April 29 at 4:00:00 PM EDT

Cogstate (ASX:CGS) Could Become A Multi-Bagger

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

Simply Wall St. 3 days ago

COGZF
0.00%
One Cogstate Insider Raised Their Stake In The Previous Year

From what we can see, insiders were net buyers in Cogstate Limited's ( ASX:CGS ) during the past 12 months. That is...

Simply Wall St. 20 days ago

COGZF
0.00%
With 37% ownership, Cogstate Limited (ASX:CGS) insiders have a lot at stake

Key Insights Cogstate's significant insider ownership suggests inherent interests in company's expansion 53% of the...

Simply Wall St. last month

COGZF
0.00%
ASX Penny Stocks To Watch Under A$200M Market Cap

After a turbulent Week 10, the Australian share market is poised for a rebound, with the ASX 200 expected to climb back over 8,000 points. In such fluctuating conditions, identifying stocks with strong financial foundations becomes crucial. While 'penny stocks' may seem like an outdated term, they still hold potential for growth and value discovery in smaller or newer companies.

Simply Wall St. last month

MLXEF

COGZF
0.00%
ALKEF
Cogstate's (ASX:CGS) investors will be pleased with their stellar 249% return over the last five years

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Simply Wall St. last month

COGZF
0.00%
Cogstate Limited Just Recorded A 9.5% Revenue Beat: Here's What Analysts Think

Shareholders of Cogstate Limited ( ASX:CGS ) will be pleased this week, given that the stock price is up 19% to AU$1.40...

Simply Wall St. 2 months ago

COGZF
0.00%
Cogstate Ltd (COGZF) (H1 2025) Earnings Call Highlights: Record Revenue and Strategic ...

Cogstate Ltd (COGZF) reports a 19% revenue increase and a promising partnership with Medidata, despite challenges in contracted future revenue.

GuruFocus.com 2 months ago

CGS.AX

DSY.PA
Spotlight On 3 ASX Penny Stocks With Market Caps Over A$10M

The Australian stock market has shown resilience with the ASX200 rising by 1% to 8,491 points, as easing tariff concerns and a stronger Aussie dollar support investor sentiment. In such a climate, identifying stocks that combine affordability with growth potential is key. While the term "penny stocks" might seem outdated, these smaller or newer companies can still offer intriguing opportunities for investors seeking value beyond the mainstream market leaders.

Simply Wall St. 2 months ago

MGL.AX

COGZF
0.00%
WMWWF
Discover 3 ASX Penny Stocks With Market Caps Over A$100M

The Australian market is experiencing a cautious start to the year, with the ASX 200 expected to open slightly lower amid global economic uncertainties and currency fluctuations. Despite these broader market challenges, penny stocks continue to attract attention as viable investment opportunities. Though often seen as relics of past trading days, penny stocks represent smaller or newer companies that can offer significant value when underpinned by strong financials. In this article, we...

Simply Wall St. 3 months ago

GWAXY

COGZF
0.00%
MAU.AX
Cogstate Limited's (ASX:CGS) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Most readers would already know that Cogstate's (ASX:CGS) stock increased by 8.3% over the past three months. Given...

Simply Wall St. 3 months ago

COGZF
0.00%
Discover ASX Penny Stocks To Watch In December 2024

The ASX200 has experienced a modest rise, with the IT sector leading gains and Health Care lagging behind. In this context, penny stocks—though an older term—still represent an intriguing investment area for those seeking opportunities in smaller or emerging companies. By focusing on firms with solid financials and growth potential, investors can uncover promising prospects among these lesser-known stocks.

Simply Wall St. 4 months ago

COGZF
0.00%
OTTEF

PPG.AX
Returns At Cogstate (ASX:CGS) Are On The Way Up

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...

Simply Wall St. 5 months ago

COGZF
0.00%
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics

NEW YORK, October 29, 2024--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience solutions leader Cogstate to reshape clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, among others.

Business Wire 5 months ago

DASTF

DASTY

COGZF
0.00%
Uncovering Opportunities: Acusensus And 2 Other ASX Penny Stocks

The Australian market remained flat over the last week but has risen 22% over the past year, with earnings forecasted to grow by 12% annually. Despite being considered an outdated term, penny stocks still represent a compelling investment area, especially for those seeking growth opportunities in smaller or newer companies. When these stocks are supported by strong financials, they can offer significant potential for returns; let's explore some examples that stand out for their balance sheet...

Simply Wall St. 6 months ago

ACE.AX

DSE.AX

COGZF
0.00%
Cogstate Insider Ups Holding During Year

From what we can see, insiders were net buyers in Cogstate Limited's ( ASX:CGS ) during the past 12 months. That is...

Simply Wall St. 6 months ago

COGZF
0.00%
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate, a leading neuroscience technology company, today announced the appointment of Kaycee Sink, MD, MAS, as Chief Medical Officer. In this role, Dr. Sink will lead Cogstate’s support of clinical trials in Alzheimer’s disease and other neurodegenerative disorders, including the advancement of new innovations to improve data quality and trial efficiency for more accurate conclusive studies. Dr. Sink will use her

GlobeNewswire 6 months ago

COGZF
0.00%
Cogstate Ltd (COGZF) Full Year 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Cogstate Ltd (COGZF) reports strong profit growth and strategic advancements despite a decline in sales contracts and future revenue projections.

GuruFocus.com 6 months ago

CGS.AX
Investors in Cogstate (ASX:CGS) have seen enviable returns of 326% over the past five years

Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...

Simply Wall St. 6 months ago

COGZF
0.00%
Cogstate Full Year 2024 Earnings: EPS Beats Expectations

Cogstate ( ASX:CGS ) Full Year 2024 Results Key Financial Results Revenue: US$43.4m (up 7.4% from FY 2023). Net income...

Simply Wall St. 7 months ago

COGZF
0.00%
Actinogen Medical stocks plummet after Phase IIa depression trial failure

Actinogen Medical’s stock dropped by 60% after the announcement that the MDD trial failed to meet its primary endpoint.

Clinical Trials Arena 8 months ago

CGS.AX

Performance Overview

Return	COGZF	S&P/ASX 200 [XJO] (^AXJO)
YTD	+34.92%	-0.40%
1-Year	-3.41%	+6.03%
3-Year	-47.53%	+9.30%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Breaking

Cogstate Limited (COGZF)

Cogstate (ASX:CGS) Could Become A Multi-Bagger

One Cogstate Insider Raised Their Stake In The Previous Year

With 37% ownership, Cogstate Limited (ASX:CGS) insiders have a lot at stake

ASX Penny Stocks To Watch Under A$200M Market Cap

Cogstate's (ASX:CGS) investors will be pleased with their stellar 249% return over the last five years

Cogstate Limited Just Recorded A 9.5% Revenue Beat: Here's What Analysts Think

Cogstate Ltd (COGZF) (H1 2025) Earnings Call Highlights: Record Revenue and Strategic ...

Spotlight On 3 ASX Penny Stocks With Market Caps Over A$10M

Discover 3 ASX Penny Stocks With Market Caps Over A$100M

Cogstate Limited's (ASX:CGS) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Discover ASX Penny Stocks To Watch In December 2024

Returns At Cogstate (ASX:CGS) Are On The Way Up

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics

Uncovering Opportunities: Acusensus And 2 Other ASX Penny Stocks

Cogstate Insider Ups Holding During Year

Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

Cogstate Ltd (COGZF) Full Year 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Investors in Cogstate (ASX:CGS) have seen enviable returns of 326% over the past five years

Cogstate Full Year 2024 Earnings: EPS Beats Expectations

Actinogen Medical stocks plummet after Phase IIa depression trial failure

Performance Overview